PCI 7 November 2023, 15:44
Temax_Krautz
Owen Mumford 12 January 2022, 17:40

Current Edition

Nasal & Pulmonary Drug Development
Staubli 11 March 2024, 13:59
Catalent: Mon 28 October 2024, 13:21
Novo Nordisk 20 March 2024, 11:21
Biosynth: Fri 4 October 2024, 10:42
Volume 15 Issue 2

Vaccine Regulation in India

Vaccines are the most important health intervention. Vaccination stimulates the immune system to identify and battle invaders such as viruses or bacteria. A vaccinat...
Continue Reading →
News

Call for ‘renewed focus’ on deadly threat from antibiotic resistance

The spectre of a dwindling supply of effective antibiotics is considered one of the gravest threats to public health – one that could soon claim more lives than canc...
Continue Reading →
News

Symcel secures €3.6 million Horizon 2020 Phase II grant for clinical validation of customized antimicrobial susceptibility testing

Symcel, the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, calScreener™, has secured €3.572 million Horizon 2020 ...
Continue Reading →
News

New treatments to solve global antibiotic crisis have potential to reach the market as early as 2020

Helperby Therapeutics (Helperby), a pioneering British biopharmaceuticals company, have developed a novel answer to the clear and present danger of antimicrobial re...
Continue Reading →
SAE Media: Fri 25 October 2024, 10:33
PHARMAP: Mon 14 October 2024, 10.36
Automa: Mon 14 October 2024, 10:22
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Stoelzle Skyscraper: 27th November 2024
LBBOHLE, Thu 20 April 2023, 17:23
Nipro 14 March 2024, 11:35
Novonordisk: Wed 17 July 2024, 13:49